Elmam Multiple Sclerosis(MS) is a virtual symposium conducted with distinctive speakers, providing a comprehensive lectures to review recent updates in management of patients with MS.
- Describe the roles of pregnancy, breastfeeding, cerebrospinal fluid (CSF) biomarkers, and blood biomarkers in managing and progressing multiple sclerosis (MS), including specific adaptations for each patient’s unique needs.
- Evaluate the effectiveness and safety of current and emerging MS therapies, including their mechanisms of action, with a focus on how they address disease-modifying needs and improve patient outcomes.
- Discuss the role of antibody-mediated demyelinating diseases of the central nervous system (CNS) in MS, distinguishing between MS and related disorders, and identify diagnostic and therapeutic strategies specific to these cases.
- Integrate current research on future therapies and advancements in biomarker and AI applications in MS to envision a holistic, personalized approach to MS care, including both conventional and novel treatments.
Fee for Non-Physician
Fee for Physician
Different Price By Specialty